DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
6.93
0.09 (1.32%)
At close: Sep 26, 2025, 3:22 PM
DiaMedica Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for DMAC stock have an median target of 12, with a low estimate of 11 and a high estimate of 14. The median target predicts an increase of 73.16% from the current stock price of 6.93.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 11 | 12.33 | 12 | 14 |
| Change | 58.73% | 77.92% | 73.16% | 102.02% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on DiaM... Unlock content with Pro Subscription
Updated Jul 18, 2025
| Rating | Oct 24 | Nov 24 | Mar 25 | May 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 3 | 0 |
| Buy | 2 | 1 | 0 | 1 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 3 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
54M
from 0
Increased by n/a%
EPS This Year
-0.68
from -0.6
Increased by -13.3%
EPS Next Year
-0.74
from -0.68
Increased by -8.8%